Envista Holdings Corp (NVST) insider trading

By person

16 insiders · 3 transactions

12.4×

Paul Keel holds 12.4 times base salary in stock. $13.67M of shares against $1.10M in salary for 2025.

Salary from the company's own proxy. The shares are what Paul Keel last reported holding, valued at $27.50, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mischa Reis

SVP, Strategy & Bus. Dev.

—

$510.25K (3) scheduled

−$510.25K

27,321

0.0170%

$751.33K

−36.0%

Paul A Keel

Chairman and CEO

—

497,107

0.3095%

$13.67M

+42.6%

Eric D. Hammes

Chief Financial Officer

—

99,913

0.0622%

$2.75M

+12.6%

R Scott Huennekens

Director

—

82,105

0.0511%

$2.26M

+48.9%

Mark E Nance

General Counsel

—

81,252

0.0506%

$2.23M

+41.4%

Barbara B. Hulit

Director

—

79,820

0.0497%

$2.20M

+15.1%

Stefan Nilsson

President, Nobel Biocare

—

61,560

0.0383%

$1.69M

+35.4%

Wendy Carruthers

Director

—

59,940

0.0373%

$1.65M

+49.3%

Christine A Tsingos

Director

—

59,930

0.0373%

$1.65M

+49.3%

Faez C Kaabi

Chief Accounting Officer

—

58,552

0.0365%

$1.61M

+31.2%

Daniel Raskas

Director

—

54,010

0.0336%

$1.49M

+57.8%

Kieran Gallahue

Director

—

54,010

0.0336%

$1.49M

+57.8%

Vivek Jain

Director

—

52,945

0.0330%

$1.46M

+59.6%

Veronica Acurio

President, Orthodontics

—

48,806

0.0304%

$1.34M

+7.4%

Robert Befidi

President, Diagnostics

—

45,785

0.0285%

$1.26M

+15.1%

James Andrew Pierce

Director

—

18,485

0.0115%

$508.34K

—

Envista Holdings Corp

What the insiders did Scheduled selling only

By person